+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Lego AS - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 31 Pages
  • July 2026
  • GlobalData
  • ID: 2653296
Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Lego AS (Lego), a subsidiary of Kirkbi A/S, designs, manufactures, and markets a wide range of toys and games. The company offers creativity development products and teaching materials for children. Its products are focused on the concept of learning and development through play. Lego's product portfolio includes traditional toys, brick-building sets, education products, and games. It also offers accessories, backpacks and lunch boxes, books, clothing, keychains, puzzles and board games, gift cards, and home decor products. The company markets products under the LEGO brand name. It has a business presence across Americas; Europe, Middle East & Africa; Asia & Pacific. Lego is headquartered in Billund, Denmark.

Lego AS Key Recent Developments

  • Oct 13, 2025: LEGO MRI Scanner Set Eases Children's Anxiety in Hospitals
  • Sep 17, 2025: LEGO Manufacturing Vietnam Signs Direct Power Purchase Agreement with VSIP

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • 3SBio Inc - Key Facts
  • 3SBio Inc - Key Employees
  • 3SBio Inc - Key Employee Biographies
  • 3SBio Inc - Major Products and Services
  • 3SBio Inc - History
  • 3SBio Inc - Company Statement
  • 3SBio Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • 3SBio Inc - Business Description
  • Other Break-up: Contract Development and Manufacturing Operation Business
  • Performance
  • Other Break-up: Licensing
  • Performance
  • Other Break-up: Sale of Biopharmaceuticals
  • Performance
  • Geographical Segment: Mainland China
  • Performance
  • Geographical Segment: Others
  • Performance
  • Geographical Segment: USA
  • Performance
  • R&D Overview
  • 3SBio Inc - Corporate Strategy
  • 3SBio Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • 3SBio Inc - Strengths
  • 3SBio Inc - Weaknesses
  • 3SBio Inc - Opportunities
  • 3SBio Inc - Threats
  • 3SBio Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • 3SBio Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 25, 2026: 3SBio Announces Poll Results of the Annual General Meeting Held on 25 June 2026; Payment of Final Dividend; and Change of Auditor
  • Mar 30, 2026: 3SBIO Releases 2025 Annual Results: Driven by Innovative R&D and Global Collaboration, It Reaches a New Milestone of 10 Billion Rmb
  • Dec 11, 2025: 3SBIO Has Been Included in the Hong Kong Stock Exchange Technology 100 Index
  • Nov 14, 2025: 3SBIO Was Listed Among the 2025 Forbes China Top 50 Innovative Companies
  • Nov 10, 2025: 3SBIO Wins the 2025 Golden Bull Award for Technological Innovation
  • Sep 19, 2025: 3SBIO Was Awarded the 2025 China Listed Companies Elite Award for Hong Kong Stock Value Demonstration Case
  • Aug 29, 2025: 3SBio : Interim Results Announcement for the Six Months Ended 30 June 2025
  • Aug 29, 2025: 3SBio Announces 2025 Interim Results: Value Realization of Innovative Achievements and Strong Long-Term Growth Momentum
  • Aug 19, 2025: Hanyu Pharmaceutical and 3SBIO Signed a Series of Commercialization Agreements, Accelerating the Progress of Their Weight Loss Drugs.
  • Jul 25, 2025: Pfizer and 3SBio conclude licensing deal for SSGJ-707
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • 3SBio Inc, Key Facts
  • 3SBio Inc, Key Employees
  • 3SBio Inc, Key Employee Biographies
  • 3SBio Inc, Major Products and Services
  • 3SBio Inc, History
  • 3SBio Inc, Other Locations
  • 3SBio Inc, Subsidiaries
  • 3SBio Inc, Key Competitors
  • 3SBio Inc, Ratios based on current share price
  • 3SBio Inc, Annual Ratios
  • 3SBio Inc, Interim Ratios
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • 3SBio Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • 3SBio Inc, Performance Chart (2021 - 2025)
  • 3SBio Inc, Ratio Charts
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026